X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
86
PharmaCompass offers a list of Imipenem + Cilastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imipenem + Cilastatin manufacturer or Imipenem + Cilastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imipenem + Cilastatin manufacturer or Imipenem + Cilastatin supplier.
PharmaCompass also assists you with knowing the Imipenem + Cilastatin API Price utilized in the formulation of products. Imipenem + Cilastatin API Price is not always fixed or binding as the Imipenem + Cilastatin Price is obtained through a variety of data sources. The Imipenem + Cilastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imipenem + Cilastatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imipenem + Cilastatin, including repackagers and relabelers. The FDA regulates Imipenem + Cilastatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imipenem + Cilastatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imipenem + Cilastatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imipenem + Cilastatin supplier is an individual or a company that provides Imipenem + Cilastatin active pharmaceutical ingredient (API) or Imipenem + Cilastatin finished formulations upon request. The Imipenem + Cilastatin suppliers may include Imipenem + Cilastatin API manufacturers, exporters, distributors and traders.
click here to find a list of Imipenem + Cilastatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Imipenem + Cilastatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imipenem + Cilastatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imipenem + Cilastatin GMP manufacturer or Imipenem + Cilastatin GMP API supplier for your needs.
A Imipenem + Cilastatin CoA (Certificate of Analysis) is a formal document that attests to Imipenem + Cilastatin's compliance with Imipenem + Cilastatin specifications and serves as a tool for batch-level quality control.
Imipenem + Cilastatin CoA mostly includes findings from lab analyses of a specific batch. For each Imipenem + Cilastatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imipenem + Cilastatin may be tested according to a variety of international standards, such as European Pharmacopoeia (Imipenem + Cilastatin EP), Imipenem + Cilastatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imipenem + Cilastatin USP).
Market Place
